Show simple item record

AuthorDoi, Suhail A R
AuthorFuruya-Kanamori, Luis
AuthorToft, Egon
AuthorMusa, Omran A H
AuthorIslam, Nazmul
AuthorClark, Justin
AuthorThalib, Lukman
Available date2019-11-04T11:09:59Z
Publication Date2019-10-01
Publication NameObesity Reviews
Identifierhttp://dx.doi.org/10.1111/obr.12964
CitationDoi, Suhail A R. et. al. Metformin in pregnancy to avert gestational diabetes in womenat high risk: Meta‐analysis of randomized controlled trials. Obesity Reviews. 2019;1–9.
ISSN1467-7881
URIhttp://hdl.handle.net/10576/12302
AbstractPrevious randomized and observational studies on the efficacy of metformin in pregnancy to reduce incident gestational diabetes mellitus (GDM) in women at high risk (obesity, polycystic ovary syndrome [PCOS], or pregestational insulin resistance) have been conflicting and several groups are planning further randomized controlled trials (RCTs) to answer this question conclusively. This work assesses the efficacy of metformin in pregnancy to avert one outcome-incident GDM in women at high risk. We included RCTs comparing metformin with usual care or placebo controls in terms of incident GDM and recruiting women at high risk during early pregnancy. Eleven eligible trials enrolled 2370 adult women whose intervention arm consisted of metformin started at conception or before 20 weeks of gestation. Risk of GDM was similar in intervention compared with controls (risk ratio [RR] 1.03; 95% confidence interval [CI], 0.85-1.24). The data were of sufficient quality meeting the criteria for consistency and directness. We conclude that metformin does not contribute to averting the GDM outcome in women at high risk when initiated in pregnancy. The evidence provided by this synthesis affirms that further broad clinical trials investigating this question are no longer needed.
SponsorQatar National Research Fund, Grant/AwardNumber: NPRP10‐0129‐170274
Languageen
PublisherWiley
Subjectgestational diabetes
insulin resistance
metformin
obesity
TitleMetformin in pregnancy to avert gestational diabetes in women at high risk: Meta-analysis of randomized controlled trials.
TypeArticle Review
Pagination1-9
ESSN1467-789X
dc.accessType Abstract Only


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record